These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1910430)

  • 1. Cyclosporin A blood levels during use of cyclosporin as oral solution or in capsules: comparison of pharmacokinetic parameters.
    Hilbrands LB; Hoitsma AJ; van den Berg JW; Koene RA
    Transpl Int; 1991 Jun; 4(2):125-7. PubMed ID: 1910430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pharmacokinetic comparison of cyclosporin oral solution and cyclosporin capsules in heart and lung transplant recipients.
    Eadon H; Rose M; O'Neill R; Leaver N; Yacoub M
    Transpl Int; 1995; 8(1):35-40. PubMed ID: 7888049
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the application form of cyclosporine on blood levels: comparison of oral solution and capsules.
    Nashan B; Bleck J; Wonigeit K; Vogt P; Christians U; Sewing KF; Beveridge T; Pichlmayr R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):637-9. PubMed ID: 3284113
    [No Abstract]   [Full Text] [Related]  

  • 4. Bioavailability and patient acceptance of cyclosporine soft gelatin capsules in renal allograft recipients.
    Min DI; Hwang GC; Bergstrom S; Madras PN; Shaffer D; Sahyoun AI; Monaco AP
    Ann Pharmacother; 1992 Feb; 26(2):175-9. PubMed ID: 1554925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical pharmacokinetics of cyclosporin.
    Ptachcinski RJ; Venkataramanan R; Burckart GJ
    Clin Pharmacokinet; 1986; 11(2):107-32. PubMed ID: 3514043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of effect of spiramycin on cyclosporin pharmacokinetics.
    Vernillet L; Bertault-Peres P; Berland Y; Barradas J; Durand A; Olmer M
    Br J Clin Pharmacol; 1989 Jun; 27(6):789-94. PubMed ID: 2667601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.
    Schädeli F; Marti HP; Frey FJ; Uehlinger DE
    Clin Pharmacokinet; 2002; 41(1):59-69. PubMed ID: 11825097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics and renal effects of cyclosporin A and cyclosporin G in renal allograft recipients.
    Gruber SA; Gallichio M; Rosano TG; Kaplan SS; Hughes SE; Urbauer DL; Singh TP; Lempert N; Conti DJ; Stein DS; Drusano G
    J Clin Pharmacol; 1997 Jul; 37(7):575-86. PubMed ID: 9243350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on the peroral absorption of the endekapeptide cyclosporine A.
    Ritschel WA; Ritschel GB; Sabouni A; Wolochuk D; Schroeder T
    Methods Find Exp Clin Pharmacol; 1989 Apr; 11(4):281-7. PubMed ID: 2755275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of cyclosporin in man following a single oral dose: relationship to body fat content.
    Waters MR; Albano JD; Sharman VL; Raman GV
    Nephrol Dial Transplant; 1989; 4(1):71-4. PubMed ID: 2494602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nyctohemeral variations of cyclosporine administered orally in renal transplant patients].
    Ramon M; Morel D; Penouil F; Grellet J; Potaux L; Saux MC; Brachet-Liermain A
    Therapie; 1989; 44(5):371-4. PubMed ID: 2814916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporin: pharmacokinetics and detailed studies of plasma and erythrocyte binding during intravenous and oral administration.
    Legg B; Gupta SK; Rowland M; Johnson RW; Solomon LR
    Eur J Clin Pharmacol; 1988; 34(5):451-60. PubMed ID: 3203704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of food and bile acid administration on the relative bioavailability of cyclosporin.
    Lindholm A; Henricsson S; Dahlqvist R
    Br J Clin Pharmacol; 1990 May; 29(5):541-8. PubMed ID: 2350530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Plasma levels of cyclosporin 6 hours after its oral administration, T6: key to the surveillance of the treatment].
    Cantarovich F; Bizzolon C; Cantarovich D; Lefrançois N; Dubernard JM; Traeger J
    Nephrologie; 1987; 8(3):111-22. PubMed ID: 3658087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stable bioavailability of cyclosporin A, regardless of food intake, from soft gelatin capsules containing a new self-nanoemulsifying formulation.
    Yang SG; Kim DD; Chung SJ; Shim CK
    Int J Clin Pharmacol Ther; 2006 May; 44(5):233-9. PubMed ID: 16724578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of isradipine on cyclosporin pharmacokinetics.
    Vernillet L; Bourbigot B; Codet JP; Le Saux L; Moal MC; Morin JF
    Fundam Clin Pharmacol; 1992; 6(8-9):367-74. PubMed ID: 1292968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low cyclosporin A blood levels and acute graft rejection in a renal transplant recipient during rifampin treatment.
    Offermann G; Keller F; Molzahn M
    Am J Nephrol; 1985; 5(5):385-7. PubMed ID: 3904451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin drug monitoring: comparison of four immunoassays and HPLC.
    Kunzendorf U; Brockmöller J; Jochimsen F; Keller F; Roots I; Walz G; Offermann G
    Klin Wochenschr; 1989 Apr; 67(8):438-41. PubMed ID: 2657205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a therapeutic range for monitoring plasma cyclosporin in renal allograft recipients?
    Ubhi CS; Woodhouse L; Guillou PJ; Giles GR
    Nephrol Dial Transplant; 1988; 3(6):814-9. PubMed ID: 3147426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of gastrointestinal inflammation and age on the pharmacokinetics of oral microemulsion cyclosporin A in the first month after bone marrow transplantation.
    Schultz KR; Nevill TJ; Balshaw RF; Toze CL; Corr T; Currie CJ; Strong DK; Keown PA
    Bone Marrow Transplant; 2000 Sep; 26(5):545-51. PubMed ID: 11019845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.